These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 18669404)
1. Substantial activity of mitoxantrone and paclitaxel in a heavily pre-treated metastatic bladder cancer patient. Schmeeckle KD; Kim JW; Sartor O J La State Med Soc; 2008; 160(1):17-8. PubMed ID: 18669404 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer. Le Visage C; Rioux-Leclercq N; Haller M; Breton P; Malavaud B; Leong K J Urol; 2004 Mar; 171(3):1324-9. PubMed ID: 14767342 [TBL] [Abstract][Full Text] [Related]
3. [Feasibility and change in the level of blood paclitaxel concentration after paclitaxel therapy for a hemodialysis patient with cisplatin resistant metastatic transitional cell cancer]. Nomata K; Sagara Y; Toubu S; Hakariya T; Tsuda S; Noguchi M; Eguchi J; Kanetaka H Gan To Kagaku Ryoho; 2002 Jul; 29(7):1247-50. PubMed ID: 12146008 [TBL] [Abstract][Full Text] [Related]
4. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy. Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600 [TBL] [Abstract][Full Text] [Related]
5. Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1. Pecorelli S; Favalli G; Gadducci A; Katsaros D; Panici PB; Carpi A; Scambia G; Ballardini M; Nanni O; Conte P; J Clin Oncol; 2009 Oct; 27(28):4642-8. PubMed ID: 19704064 [TBL] [Abstract][Full Text] [Related]
6. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents. Ozols RF J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247 [TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone in the treatment of metastatic transitional cell carcinoma of the prostate. A case report. Stewart DJ; Dahrouge S Am J Clin Oncol; 1997 Aug; 20(4):381-2. PubMed ID: 9256894 [TBL] [Abstract][Full Text] [Related]
8. Micropapillary bladder cancer. Nishizawa K; Kobayashi T; Mitsumori K; Ide Y; Watanabe J; Ogura K Int J Urol; 2005 May; 12(5):506-8. PubMed ID: 15948755 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma. Upton ML; Tangner CH; Payton ME J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428 [TBL] [Abstract][Full Text] [Related]
10. The in vitro effect of paclitaxel on a LacZ-transfected malignant transitional cell line. Vatne V; Litlekalsoey J; Wentzel-Larsen T; Hostmark J Anticancer Res; 2005; 25(3B):2097-104. PubMed ID: 16158950 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T; Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609 [TBL] [Abstract][Full Text] [Related]
12. Weekly paclitaxel therapy is effective for gastric adenosquamous carcinoma: a case report. Tohma T; Yamamoto Y; Seki Y; Takaishi S; Sakuma Y; Funami Y; Tobita K Hepatogastroenterology; 2009; 56(90):568-70. PubMed ID: 19579645 [TBL] [Abstract][Full Text] [Related]
13. [A case of angiosarcoma of pelvis with pulmonary metastases which responded to paclitaxel]. Tada Y; Takiguchi Y; Terada J; Yoshida T; Shinozaki A; Sakao S; Kasahara Y; Kurosu K; Tanabe N; Tatsumi K; Hiroshima K; Kuriyama T Gan To Kagaku Ryoho; 2007 Dec; 34(13):2275-7. PubMed ID: 18079629 [TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone-related acute myeloblastic leukaemia in a patient with metastatic hormone-refractory prostate cancer. Martinez V; Mir O; Dômont J; Bouscary D; Goldwasser F Anticancer Drugs; 2007 Feb; 18(2):233-5. PubMed ID: 17159610 [TBL] [Abstract][Full Text] [Related]
15. Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter. Papamichael D; Gallagher CJ; Oliver RT; Johnson PW; Waxman J Br J Cancer; 1997; 75(4):606-7. PubMed ID: 9052419 [TBL] [Abstract][Full Text] [Related]
17. Intra-arterial mitoxantrone/paclitaxel in angiosarcoma of the lower limb associated with chronic lymphedema (Stewart-Treves syndrome) in a patient with cervical cancer. Fujisawa Y; Ito M; Mori K; Okada S; Nakamura Y; Kawachi Y; Otsuka F Eur J Dermatol; 2011; 21(1):119-20. PubMed ID: 21233070 [No Abstract] [Full Text] [Related]
18. [Home chemotherapy]. Ichihara T Gan To Kagaku Ryoho; 2010 Dec; 37 Suppl 2():296-7. PubMed ID: 21368555 [TBL] [Abstract][Full Text] [Related]
19. Apparent beneficial effects by nab-paclitaxel in the treatment of refractory metastatic ovarian carcinoma. Agheli A; Park SC; Huang CJ; Wang JC Anticancer Drugs; 2009 Jul; 20(6):525-6. PubMed ID: 19568002 [No Abstract] [Full Text] [Related]
20. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial. Loibl S; Murmann C; Schwedler K; Warm M; Müller L; Heinrich G; Nekljudova V; von Minckwitz G Cancer Chemother Pharmacol; 2009 Apr; 63(5):953-8. PubMed ID: 18716777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]